| 1. | APC | Antigen presenting cells |
| 2. | APNA | Activatable polymer nanoagonist |
| 3. | ATP | Adenosine triphosphate |
| 4. | CCPS | Chimeric cross-linked polymersomes |
| 5. | CD8+ | Cytotoxic T cells |
| 6. | CD4+ | Helper T cells |
| 7. | CD44 | Cluster of differentiation-44 |
| 8. | Ce6 | Chlorin e6 |
| 9. | cGAMP | Cyclic guanosine monophosphate |
| 10. | CHex-Dex | 2-carboxycyclohexane-1-carboxylated dextran |
| 11. | CHex-HA | 2-carboxycyclohexane-1-carboxylated hyaluronic acid |
| 12. | CO2 | Carbon-dioxide |
| 13. | CpG | 5′-C-phosphate-G-3′ (Oligonucleotide) |
| 14. | CRT | Calreticulin |
| 15. | CTL | Cytotoxic T lymphocytes |
| 16. | CTLA-4 | Cytotoxic T-lymphocyte associated antigen 4 |
| 17. | DCs | Dendritic cells |
| 18. | DNA | Deoxy-ribo nucleic acid |
| 19. | DOPE | 1,2-dioleoyl-sn-glycero-3-phosphoetanolamine |
| 20. | DMAEMA | Dimethylaminoethyl methacrylate |
| 21. | DOX | Doxorubicin |
| 22. | DSPE-PEG | 1, 2-Distearoyl-sn-glycero-3-phosphoethanolamine-Poly(ethylene glycol) |
| 23. | EGFR | Epidermal growth factor receptor |
| 24. | FDA | Food and Drug Administration |
| 25. | GLUT 1 | Glucose transporter 1 |
| 26. | GSH | Glutathione |
| 27. | HA | Hyaluronic acid |
| 28. | HIF 1α | Hypoxia inducible factor-1 |
| 29. | HMGB1 | High mobility group box 1 |
| 30. | H2O2 | Hydrogen peroxide |
| 31. | HPAA | Hyperbranched polyamidoamine |
| 32. | HPAA-F7 | Fluorinated hyperbranched polyamidoamine |
| 33. | HPHH | 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a |
| 34. | ICD | Immunogenic cell death |
| 35. | iDC | Immature dendritic cells |
| 36. | IL-6 | Interleukin-6 |
| 37. | IL-12 | Interleukin-12 |
| 38. | IRF3 | Interferon regulatory factor 3 |
| 39. | NK cells | Natural killer cells |
| 40. | NPs | Nanoparticles |
| 41. | LASER | light amplification by stimulated emission of radiation |
| 42. | MAA | Methacrylic acid |
| 43. | mDC | Mature dendritic cells |
| 44. | MGlu-HAA | 3-methylglutarylated hyaluronic acid |
| 45. | MGlu-HPG | 3-methyl-glutarylated hyperbranched poly(glycidol) |
| 46. | MHC I | Major histocompatibility complex-I |
| 47. | NIR | Near infra red |
| 48. | OEGMA | Oligoethylene glycol methacrylate |
| 49. | OVA | Ovalbumin |
| 50. | PAA | Polyacrylic acid |
| 51. | PAM | Poly(D,L-lactic-coglycolic acid) |
| 52. | PAMAM | Polyamidoamine |
| 53. | PCL-PEG | Poly(ε-caprolactone)-poly(ethylene glycol) |
| 54. | PCL-PEI | poly-ε-caprolactone-polyethylene imine |
| 55. | PD-1 | Programmed cell death protein -1 |
| 56. | PD-L1 | Programmed death ligand -1 |
| 57. | PDSMA | Pyridyl disulfide ethyl methacrylate |
| 58. | PDT | Photodynamic therapy |
| 59. | PEG | Poly(D,L-lactide-co-glycolide) |
| 60. | PEI | Poly(ethylene glycol) |
| 61. | PEOz-PLA | Poly(2-ethyl-2-oxazoline)-poly(L-lactide) |
| 62. | PGA | Poly glycolic acid |
| 63. | pH | Potential of hydrogen |
| 64. | PiPOx | Pipecolic acid and sarcosine oxidase |
| 65. | PLA | Polylactic acid |
| 66. | PLG | Poly(D,L-lactide-co-glycolide) |
| 67. | PLGA | Poly(lactic-co-glycolic acid) |
| 68. | PMAA | Poly(methacrylic acid) |
| 69. | PNIPAAM | Poly(g-glutamic acid |
| 70. | PTT | Photothermal therapy |
| 71. | PVA | Polyinyl alcohol |
| 72. | RGD | Arginine-glycine-aspartic acid motif |
| 73. | RIG-1 | Retinoic acid-inducible gene I |
| 74. | ROS | Reactive oxygen species |
| 75. | SO2 | Sulfur dioxide |
| 76. | STING | Stimulator of interferon genes |
| 77. | TAA | Tumour associated antigens |
| 78. | TBK1 | TANK binding kinase 1 |
| 79. | TCA | Tricarboxylic acid cycle |
| 80. | TCR | T cell receptor |
| 81. | TLR 2 | Toll like receptor 2 |
| 82. | TLR 4 | Toll like receptor 4 |
| 83. | TLR7/8 | Toll like receptor 7/8 |
| 84. | TME | Tumour micro-environment |
| 85. | TNF α | Tumour necrosis factor α |
| 86. | UV | Ultraviolet |
| 87. | VEGF | Vascular endothelial growth factor |